Professor Norman Silber, the Boas-Claster Distinguished Professor in Civil Procedure at Maurice A. Deane School of Law at Hofstra University, concluded in his March 2026 analysis that a proposed mass tort settlement framework risked substantially undervaluing claims filed by cancer victims in Roundup herbicide litigation. Silber’s examination directly challenged the justification for accepting reduced settlement values, particularly the argument that pending Supreme Court action would limit plaintiffs’ options. His work raised critical questions about whether settling parties were overestimating the impact of *Monsanto Co.
v. Durnell*, the Supreme Court case widely cited as a reason to accept lower settlement offers. Silber’s review is significant because it came from a scholar with deep expertise in civil procedure and mass tort law at a moment when settlement pressure was building. His core argument was straightforward: even if the Supreme Court ruled against plaintiffs in the pending case, alternative legal claims related to Roundup would likely remain available, meaning the settlement’s proposed discounts may not have been justified by the legal uncertainty being cited.
Table of Contents
- What Concerns Did Professor Silber Raise About the Settlement Framework?
- The Roundup Settlement and Supreme Court Implications
- How Settlement Undervaluation Affects Claimants
- What Remaining Legal Claims Could Plaintiffs Pursue?
- The Tension Between Settlement Speed and Claim Value
- Hofstra Law’s Role in Mass Tort Analysis
- The Perry Weitz Mass Tort Institute’s Oversight
What Concerns Did Professor Silber Raise About the Settlement Framework?
Silber identified a fundamental problem in how settlement negotiators were weighing the risks associated with the pending Supreme Court case. The negotiating parties had argued that given the uncertainty around *Monsanto Co. v. Durnell*, claimants should accept lower settlement values to avoid the risk of losing everything if the Court ruled unfavorably. However, Silber’s analysis suggested this reasoning oversimplified the legal landscape.
If the Supreme Court limited certain claims, many other theories of liability—including state law negligence claims, failure to warn claims, and other causes of action—would likely survive and remain viable for Roundup victims. This distinction matters because it affects settlement mathematics directly. When attorneys negotiate on behalf of a class, they weigh the expected value of proceeding to trial against the certainty of a settlement offer. If one uncertain claim disappears but multiple other claims remain viable, the expected value calculation changes substantially. Silber’s position was that the settlement framework being proposed treated the Supreme Court case as more conclusive than it actually would be in practice.
The Roundup Settlement and Supreme Court Implications
The Roundup litigation presents a textbook case of how Supreme Court uncertainty can distort settlement negotiations. For years, cancer victims who alleged that Roundup’s active ingredient, glyphosate, caused their illness had pursued various legal theories. Some claims were based on the product being inherently dangerous; others on failure to warn consumers and professionals about risks. The litigation generated billions in settlements and verdicts, but negotiators recognized that an adverse Supreme Court ruling could reshape the legal terrain.
However, Silber’s analysis revealed a critical gap in this reasoning: the Supreme Court case, while important, was not likely to be a complete bar to recovery. Different claims operate under different legal frameworks. A ruling against plaintiffs in the specific procedural or substantive question presented to the Court would not necessarily eliminate state law claims based on different theories. This meant that even in a worst-case scenario, Roundup claimants would retain legal avenues for recovery, making the deep discounts in the proposed settlement harder to justify rationally.
How Settlement Undervaluation Affects Claimants
When a settlement framework undervalues claims, the harm distributes unevenly across the class. Claimants with stronger individual circumstances—those with extensive medical documentation, clear causation evidence, or significant damages—bear a smaller proportional loss. By contrast, claimants with more marginal cases or those whose evidence is less developed pay a sharper discount.
In Roundup litigation, this distinction was especially important because cancer diagnoses and latency periods created legitimate variation in how strong individual claims appeared on paper. The practical effect is that a class member diagnosed with non-Hodgkin’s lymphoma within five years of Roundup exposure might receive a settlement value closer to their fair claim value, while someone diagnosed ten years after exposure, or with a less well-established cancer type associated with glyphosate, might receive substantially less than their claim could command in individual litigation or more generous settlement. Silber’s concerns thus were not merely academic—they bore directly on how real compensation would flow to real victims.
What Remaining Legal Claims Could Plaintiffs Pursue?
Silber’s analysis pointed toward specific legal theories that would likely survive even an unfavorable Supreme Court ruling. State law negligence claims, grounded in whether Monsanto failed to exercise reasonable care in manufacturing, testing, or marketing Roundup, operate independently of whatever federal procedural or substantive rule the Supreme Court might announce. Similarly, breach of warranty claims—both express warranties about the product’s safety and implied warranties of merchantability—have their own legal basis and wouldn’t necessarily be affected by a Supreme Court decision addressing different claims.
Additionally, fraud and misrepresentation claims, based on whether Monsanto knowingly concealed or misrepresented the risks of glyphosate exposure, have long been considered distinct from other liability theories and often survive procedural or substantive limitations that apply elsewhere in tort law. This layering of legal claims meant that Roundup claimants pursuing settlement were not as confined to a single legal theory as the settlement’s discount structure seemed to assume. The existence of multiple viable paths to recovery strengthened plaintiffs’ negotiating position if they understood and communicated it clearly.
The Tension Between Settlement Speed and Claim Value
One of the persistent tensions in mass tort practice is the pressure to settle quickly versus the desire to maximize claim value. Settlement offers become less attractive the longer litigation continues, from the defendant’s perspective, because discovery costs accumulate, trial risk increases, and the number of pending claims may grow. This dynamic creates pressure on plaintiff attorneys to accept lower values earlier rather than hold out for higher values later. However, as Silber’s analysis demonstrated, accepting lower values can itself be rational only if the legal theories supporting those claims are genuinely uncertain.
In the Roundup context, the pressure to settle was particularly acute because many claimants had already waited years for resolution while the litigation worked through the courts. Impatience on the plaintiff side, combined with the defendant’s desire to cap its exposure, created a dynamic in which overstating the impact of pending Supreme Court uncertainty became tempting for negotiators. Silber’s careful analysis pushed back on this pressure by showing that the legal uncertainty did not justify the settlement discounts being offered. This type of scholarly scrutiny is important precisely because it resists the psychological and financial pressures that can otherwise lead to systematically undervalued settlements.
Hofstra Law’s Role in Mass Tort Analysis
Silber’s work was not isolated commentary; it emerged from Hofstra Law’s broader institutional commitment to studying and improving mass tort adjudication. The university’s Perry Weitz Mass Tort Institute, directed by Barbara Barron as of June 2024, explicitly exists to examine complex legal and policy issues in how mass torts are litigated and settled. This institutional framework gave Silber’s analysis a platform and a peer review structure that strengthens its credibility. The Institute’s appointment of Barron as executive director reflected a commitment to deepening scholarly attention to mass tort practice and its effects on claimants.
The existence of such dedicated institutions matters because mass tort settlements are technical matters that often escape thorough public scrutiny. Trial courts, focused on their case management duties, may not have time for deep analysis of whether settlement frameworks are economically rational. Appellate courts review settlements only in limited circumstances. Scholarly institutions like Hofstra’s Perry Weitz Institute fill this gap by providing independent analysis of whether settlements meet standards of fairness and whether the assumptions underlying them are sound.
The Perry Weitz Mass Tort Institute’s Oversight
Since Barron’s appointment, the Perry Weitz Mass Tort Institute has positioned itself as an ongoing voice in mass tort policy discussions. The Institute’s work covers not just individual settlements but broader questions about how the legal system handles cases affecting thousands or millions of people. Silber’s examination of the Roundup settlement framework exemplified this type of analysis—a detailed, expert assessment of whether a particular settlement mechanism served the interests it was designed to serve.
By bringing this work into the public sphere and into academic discourse, institutions like Hofstra’s Perry Weitz Institute help ensure that mass tort settlements are not negotiated in isolation from critical scrutiny. Silber’s March 2026 analysis thus represents exactly the kind of institutional contribution that shapes how mass tort practitioners and judges approach future settlements. When a respected scholar with Silber’s credentials publishes detailed concerns about a settlement’s economic foundation, it changes the conversation for subsequent negotiations. Claimants’ attorneys can cite the analysis to justify higher settlement values; defense counsel must acknowledge and respond to it; and judges approving future settlements can use it as a benchmark for evaluating whether proposed frameworks adequately account for the actual legal positions of the parties.
- —